| Original language | English (US) |
|---|---|
| Pages (from-to) | 2532-2534.e1 |
| Journal | Clinical Gastroenterology and Hepatology |
| Volume | 22 |
| Issue number | 12 |
| DOIs | |
| State | Published - Dec 2024 |
Funding
Funding This work was supported by P01 DK117824 from the Public Health service (John E. Pandolfino). Conflicts of interest These authors disclose the following: John E. Pandolfino reports consulting, speaking, and grant from Sandhill Scientific/Diversatek; speaking for Takeda and Astra Zeneca; speaking, consulting, patent, and license from Medtronic; speaking and consulting for Torax; and consulting for Ironwood. Peter J. Kahrilas reports consulting for Ironwood and Reckitt; and license from Medtronic. Dustin A. Carlson reports speaking, consulting and license from Medtronic; consulting for Diversatek, Braintree and Medpace; and speaking for Phathom Pharmaceuticals and Regeneron/Sanofi. The remaining author discloses no conflicts.
ASJC Scopus subject areas
- Hepatology
- Gastroenterology